Panel: Evidence based and risk informed policy making in Europe post Brexit: What may happen next?

The UK-European Brexit discussions are shrouded in uncertainty, confusion and even doubt as no one seems to know what will actually happen.

To shed some light on the ongoing Brexit discussions, we have assembled an expert manel with Dr. Maren von Fritschen from AddOn Pharma GmbH, Dr. Evangelia Petridou from Mid Sweden University and Dr. Mikael Karlsson from KTH Royal Institute of Technology. They will discuss everything from the effects of possible Brexit on the broader pharmaceutical sector, to issues of democracy and cohesion, to implications for environmental and chemical regulation.  The event will be chaired by Professor Ragnar Löfstedt who has been following Brexit closely from London and has on and off advised a number of politicians in the House of Commons, House of Lords and the European Parliament on the topic.

Panel discussion Thursday 28 March at 10.50 am. In English.